65 results
Page 3 of 4
8-K
EX-10.1
ohc5g
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
nvb9d4bryayhwdkn2
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
9x2j08v
14 May 21
Quarterly report
4:31pm
10-K
EX-10.1
lejffuhojdb9tuubd
31 Mar 21
Annual report
4:30pm
10-K
gmznk7 an9
31 Mar 21
Annual report
4:30pm
10-K
EX-10.9
oru2fozobkg41 37s
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
n77 9qlm81633g
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
S-3
EX-4.3
ku8st0x1
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.4
llr rvw4y2xs1lko47b
29 Jan 21
Shelf registration
4:48pm
S-3
lbzi7d jpuayf
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-10.1
xpep8p7n wl9
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-99.1
a20mmg0f ig00
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.1
t50ehgtfez4
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
b8a 3gk4iluvr
2 Nov 20
Prospectus supplement
12:00am